New registry to monitor brain ablation device for Tough-to-Treat epilepsy
NCT ID NCT07546253
First seen Apr 25, 2026 · Last updated May 14, 2026 · Updated 2 times
Summary
This study will follow 100 people with drug-resistant epilepsy who are treated with the OneRF Ablation System, a device that uses heat to destroy tiny areas of brain tissue causing seizures. The goal is to see how well the procedure controls seizures and reduces their severity in everyday medical practice. Researchers will also track any side effects and changes in seizure medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG RESISTANT EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.